Urokinase-type plasminogen activator (u-PA)
Ohta, S.; Sakuragawa, N.
Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 676-677
1999
ISSN/ISBN: 0047-1852 PMID: 10543210 Document Number: 502770
Document emailed within 1 workday
Related Documents
Nelles, L.; Lijnen, H.R.; Van Nuffelen, A.; Demarsin, E.; Collen, D. 1990: Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA) Thrombosis and Haemostasis 64(1): 53-60Harbeck, N.; Kates, R.E.; Look, M.P.; Meijer-Van Gelder, M.E.; Klijn, J.G.M.; Krüger, A.; Kiechle, M.; Jänicke, F.; Schmitt, M.; Foekens, J.A. 2002: Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424) Cancer Research 62(16): 4617-4622
de Maat, M.P.; Dooijewaard, G.; Meijer, P.; Binder, B.R.; Keber, D.; Risberg, B.; Kluft, C.; Jespersen, J. 2001: Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase Enhancement Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 12(6): 453-458
Lengye, E.; Singh, B.; Gum, R.; Nerlov, C.; Sabichi, A.; Birrer, M.; Boyd, D. 1995: Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene Oncogene 11(12): 2639-2648
Zhang, X.; Bu, X.; Zhen, H.; Fei, Z.; Wu, J.; Gu, J.; Yi, S.; Wang, Z. 2000: Expression and significance of urokinase-type plasminogen activator in human gliomas Chinese Medical Journal 113(9): 802-804
Herszényi, L.; Plebani, M.; Cardin, R.; Carraro, P.; De Paoli, M.; Roveroni, G.; Naccarato, R.; Farinati, F. 1995: The role of urokinase-type plasminogen activator and its inhibitor PAI-1 in gastric cancer Acta Physiologica Hungarica 83(3): 213-221
Rijken, D.C.; van der Kaaden, M.E.; Groeneveld, E.; Barrett-Bergshoeff, M.M.; van Berkel, T.J.C.; Kuiper, J. 2002: Characterization of the binding of urokinase-type plasminogen activator to the asialoglycoprotein receptor Thrombosis and Haemostasis 88(1): 83-88
Schmitt, M.; Goretzki, L.; Jänicke, F.; Calvete, J.; Eulitz, M.; Kobayashi, H.; Chucholowski, N.; Graeff, H. 1991: Biological and clinical relevance of the urokinase-type plasminogen activator (uPA) in breast cancer Biomedica Biochimica Acta 50(4-6): 731-741
Iguchi, K.; Tatsuda, Y.; Usui, S.; Hirano, K. 2007: Pamidronate down-regulates urokinase-type plasminogen activator expression in PC-3 prostate cancer cells Anticancer Research 27(6b): 3843-3848
Song, S.-j.; Hu, J.-b.; Wang, H.-x.; Wen, S.-q.; Ding, M.-p.; Huang, J.-z. 2003: Expression of urokinase-type plasminogen activator and its receptor in plasma of patients with cerebral infarction Zhonghua Yi Xue Za Zhi 83(18): 1583-1585
Koelbl, H.; Kirchheimer, J.C.; Tatra, G.; Christ, G.; Binder, B.R. 1988: Increased plasma levels of urokinase-type plasminogen activator with endometrial and cervical cancer Obstetrics and Gynecology 72(2): 252-256
Fujii, S.; Lucore, C.L.; Hopkins, W.E.; Billadello, J.J.; Sobel, B.E. 1990: Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells Thrombosis and Haemostasis 64(3): 412-419
Taponeco, F.; Curcio, C.; Giuntini, A.; Nardini, V.; Fornaciari, G.; Artini, P.G.; D'Ambrogio, G.; Genazzani, A.R. 2001: Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer Journal of Experimental and Clinical Cancer Research: Cr 20(2): 239-246
Fujishiro, S.; Kobayashi, H.; Terao, T. 1994: Urokinase-type plasminogen activator as a predictor for lymph nodes metastasis of uterine cervical cancer Nihon Sanka Fujinka Gakkai Zasshi 46(2): 129-136
Sier, C.F.; Stephens, R.; Bizik, J.; Mariani, A.; Bassan, M.; Pedersen, N.; Frigerio, L.; Ferrari, A.; Danø, K.; Brünner, N.; Blasi, F. 1998: The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients Cancer Research 58(9): 1843-1849
Braat, E.A.; Nauland, U.; Dooijewaard, G.; Rijken, D.C. 1996: A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids Thrombosis and Haemostasis 75(6): 908-914
Braat, E.A.; Los, P.; Rijken, D.C. 1998: The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: effect of thrombomodulin Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 9(5): 419-427
Kobayashi, H.; Ohi, H.; Sugimura, M.; Shinohara, H.; Fujii, T.; Terao, T. 1992: Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B Cancer Research 52(13): 3610-3614
Philippou, A.; Maridaki, M.; Koutsilieris, M. 2008: The role of urokinase-type plasminogen activator (uPA) and transforming growth factor beta 1 (TGFbeta1) in muscle regeneration In Vivo 22(6): 735-750
Chu, S-Chen.; Yang, S-Fa.; Lue, K-Huang.; Hsieh, Y-Shou.; Hsiao, T-Yan.; Lu, K-Hsiu. 2006: Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee Journal of Rheumatology 33(2): 311-317